Efficacy and safety of piecemeal submucosal tunneling endoscopic resection for giant esophageal leiomyoma

Authors Xin Li,En Liu,Xia Xie,Xue Peng,Xu-biao Nie,Jian-jun Li,Yong Gao,Lu Liu,Jian-ying Bai,Tong-chuan Wang,Chao-qiang Fan
DOI: https://doi.org/10.1016/j.dld.2024.01.193
IF: 5.165
2024-02-07
Digestive and Liver Disease
Abstract:Background and Aims Giant esophageal leiomyoma usually requires a thoracotomy or thoracoscopic surgery, which is more invasive than an endoscopic treatment . The purpose of this study is to evaluate the efficacy and safety of piecemeal submucosal tunneling endoscopic resection (P-STER) for giant leiomyoma originating from the muscularis propria (MP) layer of the esophagus. Methods This is a retrospective study. Patients with giant esophageal leiomyoma (transverse diameter ≥ 3 cm) who underwent P-STER were enrolled from November 2012 to May 2023. Clinical data and results were investigated. Results A total of 16 patients were enrolled for analysis. The lesion mean transverse diameter and longitudinal diameter were 4.22 ± 1.20 cm and 6.20 ± 1.57 cm, respectively. Our mean operation time was 195.38 ± 84.99 min. The mean number of piecemeal resected was 4.31 ± 2.36. An adverse event noted was an esophageal fistula that occurred in one case (6.25%) and was treated conservatively. The mean length of hospital stay was around 11.81 ± 7.30 days. The mean total hospitalization cost was U.S. dollars (USD) $5976.50 ± 2866.39. No recurrence or metastasis was found during the follow-up period. Conclusions P-STER can be an effective and safe treatment for giant leiomyoma originating from the MP layer of the esophagus.
gastroenterology & hepatology
What problem does this paper attempt to address?